# Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy

> **NCT00006095** · PHASE1 · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 20 (actual)

## Conditions studied

- Unspecified Childhood Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** irinotecan hydrochloride
- **DRUG:** vincristine sulfate

## Key facts

- **NCT ID:** NCT00006095
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-07
- **Primary completion:** 2005-01
- **Final completion:** 2005-09
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-02-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006095, "Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00006095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*